MYGN

Myriad Genetics, Inc. Press Releases

$36.65
*  
0.15
0.41%
Get MYGN Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading MYGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Myriad Genetics Names Bernard Tobin as President of Crescendo Bioscience
12/22/2014 7:00:00 AM - GlobeNewswire


Myriad Receives FDA Approval of BRACAnalysis CDx(TM) as Companion Diagnostic for Lynparza(TM) (olaparib) in Ovarian Cancer Patients
12/19/2014 12:10:00 PM - GlobeNewswire


Three New Myriad Studies Highlighted at 2014 San Antonio Breast Cancer Symposium
12/9/2014 9:00:00 AM - GlobeNewswire


Myriad to Present Eight Studies at 2014 San Antonio Breast Cancer Symposium
12/3/2014 7:00:00 AM - GlobeNewswire


Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years
12/2/2014 7:00:00 AM - GlobeNewswire


TESARO and Myriad Announce Companion Diagnostics Collaboration
11/20/2014 7:45:00 AM - GlobeNewswire


Crescendo Bioscience Highlights New Clinical Data on Vectra(R) DA at ACR
11/19/2014 7:05:00 AM - GlobeNewswire


Crescendo Bioscience to Feature New Data on Vectra(R) DA at 2014 ACR Meeting
11/10/2014 7:05:00 AM - GlobeNewswire


Myriad myPath(TM) Melanoma Improves Diagnosis and Treatment Plans
11/7/2014 7:05:00 AM - GlobeNewswire


Myriad Genetics Reports Fiscal First Quarter 2015 Financial Results
11/4/2014 4:05:00 PM - GlobeNewswire


Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM)
11/3/2014 7:05:00 AM - GlobeNewswire


Myriad Genetics to Present at the 2014 Credit Suisse Annual Healthcare Conference
10/29/2014 4:05:00 PM - GlobeNewswire


Myriad Announces Inclusion of Prolaris(R) Test in NCCN Guidelines
10/27/2014 7:05:00 AM - GlobeNewswire


Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe
10/24/2014 9:26:00 AM - GlobeNewswire


Myriad Genetics to Announce 1Q15 Financial Results on November 4, 2014
10/21/2014 7:05:00 AM - GlobeNewswire


Myriad Genetics to Announce 1Q15 Financial Results on November 4, 2014
10/21/2014 7:05:00 AM - GlobeNewswire


Myriad Receives Draft Medicare Coverage for Prolaris(R)
10/17/2014 7:05:00 AM - GlobeNewswire


Myriad Appoints R. Bryan Riggsbee as Chief Financial Officer
10/8/2014 4:05:00 PM - GlobeNewswire


Myriad Presents Tumor BRACAnalysis CDx(TM) Study at ESMO
9/29/2014 7:30:00 AM - GlobeNewswire